International Journal of Infection

Published by: Kowsar

Investigation of IgG and IgM Antibodies Against Toxoplasma gondii Among Diabetic Patients

Mohammad Jafari Modrek 1 , 2 , Ramin Saravani 3 , 4 , * , Mohammad Mousavi 1 , 2 , Alireza Salimi Khorashad 1 , 2 and Maryam Piri 5
Authors Information
1 Infectious Disease and Tropical Medicine Research Center, Zahedan, IR Iran
2 Department of Medical Parasitology, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Cellular and Molecular Research Center, Zahedan, IR Iran
4 Department of Clinical Biochemistry, Zahedan University of Medical Sciences, Zahedan, IR Iran
5 Diabetes Center, Ali Asghar Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: July 01, 2015, 2 (3); e27595
  • Published Online: March 20, 2015
  • Article Type: Research Article
  • Received: February 2, 2015
  • Revised: February 10, 2015
  • Accepted: February 21, 2015
  • DOI: 10.17795/iji27595

To Cite: Jafari Modrek M, Saravani R, Mousavi M, Salimi Khorashad A, Piri M. Investigation of IgG and IgM Antibodies Against Toxoplasma gondii Among Diabetic Patients, Int J Infect. 2015 ; 2(3):e27595. doi: 10.17795/iji27595.

Abstract
Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Carruthers VB. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Trop. 2002; 81(2): 111-22[PubMed]
  • 2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004; 363(9425): 1965-76[DOI][PubMed]
  • 3. Webster JP, Kaushik M, Bristow GC, McConkey GA. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? J Exp Biol. 2013; 216: 99-112[DOI][PubMed]
  • 4. Shirbazou S, Delpisheh A, Mokhetari R, Tavakoli G. Serologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients. Iran Red Crescent Med J. 2013; 15(8): 701-3[DOI][PubMed]
  • 5. Gokce C, Yazar S, Bayram F, Gundogan K, Yaman O, Sahin I. Anti-Toxoplasma gondii antibodies in type 2 diabetes. Natl Med J India. 2008; 21(1): 51[PubMed]
  • 6. Kijlstra A, Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. Int J Parasitol. 2008; 38(12): 1359-70[DOI][PubMed]
  • 7. Casartelli-Alves L, Boechat VC, Macedo-Couto R, Ferreira LC, Nicolau JL, Neves LB, et al. Sensitivity and specificity of serological tests, histopathology and immunohistochemistry for detection of Toxoplasma gondii infection in domestic chickens. Vet Parasitol. 2014; 204(3-4): 346-51[DOI][PubMed]
  • 8. Bertoldi AD, Kanavos P, Franca GV, Carraro A, Tejada CA, Hallal PC, et al. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health. 2013; 9: 62[DOI][PubMed]
  • 9. Silveira C, Vallochi AL, Rodrigues da Silva U, Muccioli C, Holland GN, Nussenblatt RB, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol. 2011; 95(3): 396-400[DOI][PubMed]
  • 10. Yamakawa R, Yamashita Y, Yano A, Morita J, Kato H. Congenital toxoplasmosis complicated by central diabetes insipidus in an infant with Down syndrome. Brain Dev. 1996; 18(1): 75-7[PubMed]
  • 11. Cavallazzi LO. [Toxoplasmosis of the central nervous system in a diabetic patient]. Arq Neuropsiquiatr. 1985; 43(3): 319-21[PubMed]
  • 12. Bellali H, Pelloux H, Villena I, Fricker-Hidalgo H, Le Strat Y, Goulet V. Prevalence of toxoplasmosis in France in 1998: is there a difference between men and women? At what age do children become infected? Rev Epidemiol Sante Publique. 2013; 61(4): 311-7[DOI][PubMed]
  • 13. Barbosa IR, de Carvalho Xavier Holanda CM, de Andrade-Neto VF. Toxoplasmosis screening and risk factors amongst pregnant females in Natal, northeastern Brazil. Trans R Soc Trop Med Hyg. 2009; 103(4): 377-82[DOI][PubMed]
  • 14. Sarkar MD, Anuradha B, Sharma N, Roy RN. Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a tertiary-care hospital of Andhra Pradesh, India. J Health Popul Nutr. 2012; 30(1): 87-92[PubMed]
  • 15. Nissapatorn V, Suwanrath C, Sawangjaroen N, Ling LY, Chandeying V. Toxoplasmosis-serological evidence and associated risk factors among pregnant women in southern Thailand. Am J Trop Med Hyg. 2011; 85(2): 243-7[DOI][PubMed]
  • 16. Al-Mendalawi MD. The investigation of congenital toxoplasmosis in a tertiary care hospital in Turkey. Saudi Med J. 2010; 31(1): 96[PubMed]
  • 17. Berger F, Goulet V, Le Strat Y, Desenclos JC. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Rev Epidemiol Sante Publique. 2009; 57(4): 241-8[DOI][PubMed]
  • 18. Cantella R, Colichon A, Lopez L, Wu C, Goldfarb A, Cuadra E, et al. Toxoplasmosis in Peru. Geographic prevalence of Toxoplasma gondii antibodies in Peru studied by indirect fluorescent antibody technique. Trop Geogr Med. 1974; 26(2): 204-9[PubMed]
  • 19. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol. 1997; 35(1): 174-8[PubMed]
  • 20. Siyadatpanah A, Tabatabaie F, Oormazdi H, Reza A, Meamar ER, Hadighi R, et al. Comparison of anti-toxoplasma IgG and IgM antibodies determined by ELISA method in diabetic and non-diabetic individuals in west Mazandaran province, Iran, 2011-2012. Ann Biol Res. 2013; 4(6): 281-5
  • 21. Han K, Shin DW, Lee TY, Lee YH. Seroprevalence of Toxoplasma gondii infection and risk factors associated with seropositivity of pregnant women in Korea. J Parasitol. 2008; 94(4): 963-5[DOI][PubMed]
  • 22. Zemene E, Yewhalaw D, Abera S, Belay T, Samuel A, Zeynudin A. Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia. BMC Infect Dis. 2012; 12: 337[DOI][PubMed]
  • 23. Sarkari B, Shafiei R, Zare M, Sohrabpour S, Kasraian L. Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran. J Infect Dev Ctries. 2014; 8(4): 543-7[DOI][PubMed]
  • 24. Waree P, Ferguson DJ, Pongponratn E, Chaisri U, Sukthana Y. Immunohistochemical study of acute and chronic toxoplasmosis in experimentally infected mice. Southeast Asian J Trop Med Public Health. 2007; 38(2): 223-31[PubMed]
  • 25. Hofgartner WT, Swanzy SR, Bacina RM, Condon J, Gupta M, Matlock PE, et al. Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems. J Clin Microbiol. 1997; 35(12): 3313-5[PubMed]
  • 26. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13): 1217-58[PubMed]
  • 27. Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008; 38(11): 1257-78[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments